RxDoctor Payments DataLook up a doctor →

Raam Sambandam, MD

Clinical Neurophysiology · Clermont, FLNPI 1528226388

Payments from drug & device makers

$80,973in general payments, 2019–2025

Across 1,647 payments — averaging $49.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$27K
  • Argenx US, Inc.$16K
  • Grifols USA, LLC$4K
  • E.r. Squibb & Sons, L.L.C.$3K
  • UCB, Inc.$3K
  • Novartis$3K
  • plus $24K from 54 others

What the payments were for

  • Consulting fees$19,55124%
  • Speaking & faculty fees$25,35832%
  • Travel & lodging$4,8026%
  • Food & beverage$30,31038%
  • Education$600%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC71$26,903
Argenx US, Inc.111$16,335
Grifols USA, LLC22$3,677
E.r. Squibb & Sons, L.L.C.4$3,386
UCB, Inc.90$3,189
Novartis95$2,910
AbbVie(2 entities)103$1,877
Biogen58$1,551
Bristol Myers Squibb40$1,408
Neurocrine Biosciences, Inc.72$1,356
Pfizer74$1,227
MDD US Operations, LLC91$1,170
Supernus Pharmaceuticals, Inc.112$1,087
Teva Pharmaceuticals USA, Inc.66$1,062
Acadia Pharmaceuticals Inc60$888
Sanofi37$807
Livanova USA, Inc.8$798
Eisai Inc.36$689
Amgen(2 entities)27$644
AstraZeneca27$612
SK Life Science, Inc.24$601
CSL Behring25$598
EMD Serono, Inc.24$519
TG Therapeutics, Inc.16$483
Lundbeck LLC27$481
Amneal Pharmaceuticals LLC25$481
Genentech USA, Inc.25$478
Takeda Pharmaceuticals U.S.A., Inc.20$442
Sunovion Pharmaceuticals Inc.23$377
Neurelis, Inc.15$298
Johnson & Johnson(2 entities)12$275
Otsuka America Pharmaceutical, Inc.13$271
Merz Pharmaceuticals, LLC11$264
Mallinckrodt Hospital Products Inc.14$262
Abbott3$261
Upsher-smith Laboratories LLC10$232
Avanir Pharmaceuticals, Inc.12$219
Biohaven Pharmaceutical Holding Company Ltd.16$203
Catalyst Pharmaceuticals, Inc.8$195
Adamas Pharmaceuticals, Inc.11$185
Acorda Therapeutics, Inc9$176
Sumitomo Pharma America, Inc.8$157
Impel Pharmaceuticals Inc.10$154
Boston Scientific6$154
Tanabe Pharma America, Inc.8$154
Insightec,inc2$133
Alnylam Pharmaceuticals Inc.4$107
Banner Life Sciences, LLC5$107
Corium, LLC6$103
Avion Pharmaceuticals5$96
Octapharma USA, Inc.1$87
GE HealthCare4$78
Biohaven Pharmaceuticals, Inc.4$77
Bausch Health US, LLC4$60
Zyla Life Sciences, Inc.4$57
Impel Pharmaceuticals LLC3$53
Jazz Pharmaceuticals Inc.2$47
Life Molecular Imaging Ltd3$44
C2n Diagnostics, LLC2$43
GRT US Holding, Inc.1$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical neurophysiology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$4,702,784
Medicare patients
897
Services billed
317,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GammakedImmune Globul G/Gly/Iga Avg 4680$1,003,860
OctagamImmun Globg(Igg)/Malt/Iga Ov5020$937,498
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5068$416,967
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5018$248,174
Gamunex-CImmune Globul G/Gly/Iga Avg 4622$142,135
AustedoDeutetrabenazine13$123,401
GocovriAmantadine Hcl42$117,161
BotoxOnabotulinumtoxina48$77,621
QuliptaAtogepant57$71,045
Nurtec OdtRimegepant Sulfate36$64,439
NuplazidPimavanserin Tartrate13$63,043
UbrelvyUbrogepant31$41,162
RexultiBrexpiprazole11$29,876
Aimovig AutoinjectorErenumab-Aooe25$29,783
AptiomEslicarbazepine Acetate11$26,242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerOctagam, Nurtec Odt$1,227$1,001,93756 claims
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$442$416,96768 claims
CSL BehringPrivigen$598$248,17418 claims
AbbVieBotox, Qulipta, Ubrelvy$1,877$189,828136 claims
Grifols USA, LLCGamunex-C$3,677$142,13522 claims
Teva Pharmaceuticals USA, Inc.Austedo$1,062$123,40113 claims
MDD US Operations, LLCGocovri$1,170$117,16142 claims
Acadia Pharmaceuticals IncNuplazid$888$63,04313 claims
Otsuka America Pharmaceutical, Inc.Rexulti$271$29,87611 claims
Amneal Pharmaceuticals LLCRytary, Mycophenolate Mofetil$481$28,28428 claims
Sunovion Pharmaceuticals Inc.Aptiom$377$26,24211 claims
Neurocrine Biosciences, Inc.Ongentys$1,356$7,41611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in Floridaon file to place this against a meaningful peer group, so we don't.

Other clinical neurophysiology in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →